| Dr Michelle Morris Harrison, OD | |
|
264 Highway 641 N, Camden, TN 38320-1329 | |
| (731) 584-7942 | |
| (731) 584-7965 |
| Full Name | Dr Michelle Morris Harrison |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 29 Years |
| Location | 264 Highway 641 N, Camden, Tennessee |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982696498 | NPI | - | NPPES |
| 5848609 | Other | TN | AETNA |
| 004006095 | Other | TN | TENNCARE SELECT |
| 200721045001 | Other | TN | TRICARE |
| 3723849 | Medicaid | TN | |
| 4266337 | Other | TN | CIGNA |
| P00193746 | Other | TN | RAILROAD MEDICARE |
| 004006095 | Other | TN | ANTHEM BLUE CROSS BLUE SH |
| 004006095 | Other | TN | BLUE CROSS BLUE SHIELD |
| 200721045 | Other | TN | OMNICARE |
| 200721045 | Other | TN | HEALTH PARTNERS |
| 200721045 | Other | TN | BOILERMAKERS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD0000001677 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hermitage Eye Care, Pllc | 0446576359 | 40 |
News Archive
Mater Children's Hospital and Masimo today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities. The conversion equips the tertiary facility with the most technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions available.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 4 days ago
| Provider Name | Camden Eye Care Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609868363 PECOS PAC ID: 0648243303 Enrollment ID: O20040819000693 |
News Archive
Mater Children's Hospital and Masimo today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities. The conversion equips the tertiary facility with the most technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions available.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 4 days ago
| Provider Name | Harrison Eye Clinic, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114089091 PECOS PAC ID: 7012082852 Enrollment ID: O20080903000555 |
News Archive
Mater Children's Hospital and Masimo today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities. The conversion equips the tertiary facility with the most technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions available.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 4 days ago
| Provider Name | Hermitage Eye Care, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275943052 PECOS PAC ID: 0446576359 Enrollment ID: O20150311000798 |
News Archive
Mater Children's Hospital and Masimo today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities. The conversion equips the tertiary facility with the most technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions available.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Morris Harrison, OD 111 E 4th St Ste 440, Alton, IL 62002-6241 Ph: (618) 462-9818 | Dr Michelle Morris Harrison, OD 264 Highway 641 N, Camden, TN 38320-1329 Ph: (731) 584-7942 |
News Archive
Mater Children's Hospital and Masimo today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring capabilities. The conversion equips the tertiary facility with the most technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions available.
In the last decade, a new strain of MRSA has emerged that can spread beyond hospital walls, putting everyone at risk of contracting the dangerous bacterial infection. This particular strain of MRSA - known as USA300 - contains a chunk of genes not shared by any other strains, though it is unclear how this unique genetic material enables the bacteria to survive and persist in the community.
Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 4 days ago
Dr. William Hall Mcconnell, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 194 W. Main St., Camden, TN 38320 Phone: 731-584-6161 Fax: 731-584-6606 | |
Dr. Emma W Scott, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 264 Highway 641 N, Camden, TN 38320 Phone: 731-584-7942 | |
Big Rock Eye Care Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 2200 Highway 641 N, Camden, TN 38320 Phone: 731-676-2028 | |
Camden Eye Care Associates Optometrist Medicare: Medicare Enrolled Practice Location: 264 Highway 641 N, Camden, TN 38320 Phone: 731-584-7942 Fax: 731-584-7965 | |
Ross B Lumpkin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2200 Highway 641 N, Camden, TN 38320 Phone: 731-599-2020 |